Literature DB >> 31166518

[Multimorbidity profile associated with disability among the elderly living in the Metropolitan Region of Belo Horizonte, Brazil].

Gabriella Marques Bernardes1, Juliana Vaz de Melo Mambrini1,2, Maria Fernanda Lima-Costa1,2, Sérgio Viana Peixoto1,2,3.   

Abstract

The scope of this paper was to investigate the associations of disability in three domains (BADL, IADL and mobility) with cardiovascular diseases, diabetes and multimorbidity profile, among the elderly living in the Metropolitan Region of Belo Horizonte (MRBH). A cross-sectional study was conducted with a representative sample of 2,172 elderly persons (60 years and over). Disability, for each domain (BADL, IADL and mobility), was assessed as reporting great difficulty or need for help to perform at least one activity among those investigated, and self-reported diseases included arterial hypertension, myocardial infarction or angina, stroke, diabetes, and combinations of these diseases. Adjusted Poisson regression was used, and the attributable population fraction was also estimated. A major contribution of Cerebral Vascular Accidents (strokes) to disability in all domains was observed, especially BADLs, as well as the presence of infarction or angina in disability in IADLs and mobility, especially when combined with diabetes and hypertension. The multimorbidity profile can be used to identify vulnerable groups, which should be the target of prevention and rehabilitation, reducing the financial and social cost of this event among the elderly.

Entities:  

Mesh:

Year:  2019        PMID: 31166518     DOI: 10.1590/1413-81232018245.17192017

Source DB:  PubMed          Journal:  Cien Saude Colet        ISSN: 1413-8123


  1 in total

1.  Integrated Care in the Community: The Case of the Programa Maior Cuidado (Older Adult Care Programme) in Belo Horizonte-Minas Gerais, BRA.

Authors:  Janaína de Souza Aredes; Jenny Billings; Karla Cristina Giacomin; Peter Lloyd-Sherlock; Josélia Oliveira Araújo Firmo
Journal:  Int J Integr Care       Date:  2021-06-21       Impact factor: 5.120

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.